Compare
Groupon, Inc. vs Criteo S.A. vs Stran & Company, Inc. vs Haoxi Health Technology Ltd
| Latest fiscal year | Groupon, Inc. GRPN | Criteo S.A. CRTO | Stran & Company, Inc. SWAGW | Haoxi Health Technology Ltd HAO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-06-30 |
| Revenue | $498.42M | $1.94B | $116.19M | $32.80M |
| Revenue growth (YoY) | +1.2% | +0.6% | +40.6% | -32.4% |
| Gross margin | 90.8% | 54.0% | 29.5% | 2.8% |
| Operating margin | 4.7% | 10.4% | -1.7% | -6.1% |
| Net margin | -16.8% | 7.4% | -0.6% | 11.8% |
| Net income | -$83.52M | $144.60M | -$747.0K | $3.88M |
| EPS (Diluted) | -$2.08 | $2.64 | -$0.04 | $1.32 |
| Operating cash flow | $64.50M | $311.24M | -$4.67M | -$3.36M |
| Free cash flow | $49.87M | $208.50M | -$5.50M | n/a |
| Cash & equivalents | $296.08M | $342.04M | $6.75M | n/a |
| Total assets | $670.41M | $2.20B | $49.35M | $21.60M |
| Total liabilities | $712.80M | $1.02B | $18.85M | $4.22M |
| Shareholders' equity | -$42.39M | $1.19B | $30.50M | $17.38M |
| Return on year-end equity | n/a | 12.2% | -2.4% | 22.3% |
| Shares outstanding | 40.73M | 51.15M | 18.51M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Groupon, Inc. | Criteo S.A. | Stran & Company, Inc. | Haoxi Health Technology Ltd |
|---|---|---|---|---|
| Latest | $498.42M Ended 2025-12-31 | $1.94B Ended 2025-12-31 | $116.19M Ended 2025-12-31 | $32.80M Ended 2025-06-30 |
| 1 year earlier | $492.56M Ended 2024-12-31 | $1.93B Ended 2024-12-31 | $82.65M Ended 2024-12-31 | $48.52M Ended 2024-06-30 |
| 2 years earlier | $514.91M Ended 2023-12-31 | $1.95B Ended 2023-12-31 | $76.00M Ended 2023-12-31 | $28.23M Ended 2023-06-30 |
| 3 years earlier | $599.09M Ended 2022-12-31 | $2.02B Ended 2022-12-31 | $57.88M Ended 2022-12-31 | $16.16M Ended 2022-06-30 |
| 4 years earlier | $967.11M Ended 2021-12-31 | $2.25B Ended 2021-12-31 | $39.70M Ended 2021-12-31 | n/a |